跳至主要内容
临床试验/NL-OMON47821
NL-OMON47821已完成2 期

5-AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR THE TREATMENT OF PREMALIGNANT DISORDERS OF THE VULVA - ALA-PDT for premalignant vulvar disorders

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Histologically proven HSIL, without invasion or clinically proven VLS
  • - The patient is willing to use a medically acceptable method of contraception throughout the study.
  • - Age 18 and above

排除标准

  • - (Micro-)invasive carcinoma
  • - Pregnancy and/or breastfeeding
  • - Past history of vulvar cancer
  • - Differentiated (non HPV-related) VIN
  • - Other treatment of VIN, anogenital warts or LS within 1 month of start treatment
  • - Hypersensitivity to any components of the ointment formulations
  • - History of psoriasis or other inflammatory dermatosis of the vulva
  • - Insufficient understanding of the Dutch language

研究者

相似试验

5-AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR THE... | 临床试验